Daiichi Sankyo Co. Ltd. (TYO:4568) is entering Japan’s market for anti-cancer cell therapy drugs in partnership with U.S.-based Kite Pharma…...
Please subscribe to read the full story.
Japan's leading chemical industry newspaper
Footer
© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.
